Pienta Kenneth 4
4 · Cue Biopharma, Inc. · Filed Dec 21, 2021
Insider Transaction Report
Form 4
Pienta Kenneth
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2021-12-20+80,000→ 80,000 totalExercise: $11.45Exp: 2031-12-20→ Common Stock (80,000 underlying)
Footnotes (1)
- [F1]This stock option grant becomes exercisable in four equal semi-annual installments beginning June 20, 2022.